OncoLink Cancer Resource Home
OncoLink Cancer Resource Home
OncoLink Cancer Resource Home
OncoLink Cancer Resource Home OncoLink
OncoLink Cancer Resource Home
 OncoLink en espanol OncoLink en espanõl Thursday, August 28, 2008OncoLink Cancer Resource Home
OncoLink Cancer Resource Home
GEMZAR HCP
Search Cancer Information

Advanced Search
OncoLink Cancer Resource Home
Types of Cancer Types of Cancer
OncoLink Cancer Resource
Cancer Treatment Information Cancer Treatment Information
OncoLink Cancer Resource
Coping with Cancer Coping with Cancer
OncoLink Cancer Resource
Cancer Clinical Trials Matching Service Cancer Clinical Trials Matching
OncoLink Cancer Resource
Cancer Resources and News Cancer Resources and News
OncoLink Cancer Resource
Ask the Cancer Experts Ask the Cancer Expert
OncoLink Cancer Resource
OncoLink Cancer Library OncoLink Library
OncoLink Cancer Resource
Cancer and Oncology Sponsors Sponsors
OncoLink Cancer Resource
About Oncolink's Cancer Resources About OncoLink
OncoLink
Giving to Oncolink's Cancer Resources Giving to OncoLink
Oncolink Cancer Resource Home
OncoLink's Cancer Tip of the Day
OncoLink Nurses' Notes
OncoLink OncoPilot
Continuing Medical Education
Continuing Education
Monthly Cancer Information Newsletter

Cancer Clinical Trials Matching

OncoLink Cancer Art Gallery
 
OncoLink Cancer Resource Home Cancer News
OncoLink Cancer News - Reuters Thursday August 28, 2008
The latest news on cancer treatment, cancer research, oncology advances, and cancer clinical trials.
OncoLink Cancer Resource Home UK's NICE recommends Novartis eye drug Lucentis ...more
OncoLink Cancer Resource Home Bortezomib added to melphalan improves myeloma response ...more
OncoLink Cancer Resource Home Estrogen receptor-beta status influences breast cancer prognosis ...more
OncoLink Cancer Resource Home Pegylated liposomal doxorubicin prevents relapse of HIV-related Kaposi sarcoma ...more
OncoLink Cancer Resource Home Levonorgestrel IUD may increase breast cancer relapse risk in some patients ...more
OncoLink Cancer Resource Home Amifostine lowers risk of cisplatin-related hearing loss in children ...more
More Cancer News
 
OncoLink Cancer Resource Home Hot Spot

Oncolife

OncoLink has created an individualized plan of care based on the Institute of Medicine recommendations for cancer survivors. This free and easy to use program provides cancer survivors with information regarding the health risks they face as a result of cancer therapies. It encourages them to review the plan with their healthcare team to further assess their risk and become active participants in their follow up care.

Develop your survivorship care plan today!

OncoLink en espanol Oncolife en espanõl

OncoLink Cancer Resource Home
OncoLink Cancer Resource Home What's New

Ask The Experts
This is your chance to "Ask the Experts" everything you've always wanted to know about types of cancer, cancer treatments and cancer side effects.

Legal Words of Wisdom: Power of Attorney
Brought to you by the Legal Clinic for the Disabled, Inc.

Greetings from CancerLand: Deleterious Mutation
OncoLink's Poet-in-Residence Alysa Cummings intimately shares her reaction to some devastating news.

OncoLink eNews: August 2008
Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania.

View all new items

 
OncoLink Cancer Resource Home Cancer Awareness

“Eat your way to better health. What you eat (or don't eat) and how active you are can influence your risk of developing cancer. Learn about the best ways to reduce your risk through simple lifestyle changes.”

Accept the American Cancer Society’s Great American Eat Right Challenge

“Find out what current science can tell us about the roles of certain foods, such as soy, flaxseed and green tea, in protecting our health.”

Get the Facts on Foods that Fight Cancer from The American Institute for Cancer Research

Got a Food and Cancer related question?

Ask the Expert Cancer Center Dieticians at OncoLink